SHANGHAI — China's vaccine developers stuck with unused mRNA Covid shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies — Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics — came up with mRNA vaccines that won limited emergency approvals...
Related Keywords
Australia , Beijing , China , Indonesia , Malaysia , Shanghai , Laos , Malaysian , Chinese , Robert Langer , Ying Bo , Kongxay Phounphenghack , Abogen Biosciences , Li Hangwen , Frank Zhang , Stemirna Covid , Dicky Budiman , George Gao , Davone Duangdany , Reuters , Child Health Center , Chinese Academy Of Sciences Institute Microbiology , Chinese Center , Griffith University , World Health Organisation , Walvax Biotechnology , Stemirna Therapeutics , Chinese Academy , Sciences Institute , Chinese Center For Disease Control , Malaysia Pharmaniaga ,
comparemela.com © 2020. All Rights Reserved.